Lack of Prophylactic Efficacy of Oral Maraviroc in Macaques despite High Drug Concentrations in Rectal Tissues

Maraviroc (MVC) is a potent CCR5 coreceptor antagonist that is in clinical testing for daily oral pre-exposure prophylaxis (PrEP) for HIV prevention. We used a macaque model consisting of weekly SHIV(162p3) exposures to evaluate the efficacy of oral MVC in preventing rectal SHIV transmission. MVC do...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Massud, Ivana, Aung, Wutyi, Martin, Amy, Bachman, Shanon, Mitchell, James, Aubert, Rachael, Solomon Tsegaye, Theodros, Kersh, Ellen, Pau, Chou-Pong, Heneine, Walid, García-Lerma, J. Gerardo
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society for Microbiology 2013
विषय:
Vaccines and Antiviral Agents
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3754060/
https://ncbi.nlm.nih.gov/pubmed/23740994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01204-13
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन